Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. MCS
MCS logo

MCS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Marcus Corp (MCS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
18.610
1 Day change
-0.16%
52 Week Range
20.020
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Marcus Corp (MCS) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company has shown strong financial performance in its latest quarter, with significant YoY growth in revenue, net income, and EPS. Technical indicators are bullish, and the stock is trading near its support level, presenting a potential entry point. Despite insider selling, the positive catalysts outweigh the negatives, making it a favorable choice for long-term investment.

Technical Analysis

The MACD is positive and contracting, indicating bullish momentum. RSI is neutral at 54.189, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its pivot level of 18.433, with key resistance at 19.388 and support at 17.478.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
1
Buy
10

Positive Catalysts

  • Positive trends in RevPAR growth, concession optimization, and favorable film mix.

Neutral/Negative Catalysts

  • Insider selling has increased significantly by 5516.54% over the last month. No significant hedge fund activity. Options data indicates low trading activity.

Financial Performance

In Q4 2025, revenue increased by 3.10% YoY to $193.5M, net income surged by 504.06% YoY to $5.96M, and EPS rose by 533.33% YoY to $0.19. Gross margin improved by 3.50% YoY to 31.01%.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

B. Riley analyst Drew Crum raised the price target to $23 from $22 and maintained a Buy rating, citing modest outperformance in Theatres and Hotels segments and positive trends in RevPAR growth and concession optimization.

Wall Street analysts forecast MCS stock price to rise
2 Analyst Rating
Wall Street analysts forecast MCS stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 19.160
sliders
Low
22
Averages
23.5
High
25
Current: 19.160
sliders
Low
22
Averages
23.5
High
25
B. Riley
Buy
maintain
$23 -> $25
AI Analysis
2026-04-17
Reason
B. Riley
Price Target
$23 -> $25
AI Analysis
2026-04-17
maintain
Buy
Reason
B. Riley raised the firm's price target on Marcus to $25 from $23 and keeps a Buy rating on the shares as part of the firm's Q1 earnings preview for the film exhibitor stocks.
B. Riley
Drew Crum
maintain
$22 -> $23
2026-02-27
Reason
B. Riley
Drew Crum
Price Target
$22 -> $23
2026-02-27
maintain
Reason
B. Riley analyst Drew Crum raised the firm's price target on Marcus to $23 from $22 and keeps a Buy rating on the shares. Marcus reported Q4 results with revenue of $193.5M and AEBITDA of $26.8M, beating forecasts and reflecting modest outperformance in both Theatres and Hotels segments, the analyst tells investors in a research note. With RevPAR growth, concession optimization, and favorable film mix, the firm says.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for MCS
Unlock Now

People Also Watch